Home > products  >  phospholipids 
					>  lipids-for-drug-delivery 
					>  cationic-liposomes-lyophosome-pegylated-dspc-chol-dstap-peg2000-dspe-60-30-5-5-molar-ratio
				
				Cationic Liposomes (Lyophosome-PEGylated)(DSPC:Chol:DSTAP:PEG2000-DSPE (60:30:5:5 molar ratio))
Cationic Liposomes (Lyophosome-PEGylated)(DSPC:Chol:DSTAP:PEG2000-DSPE (60:30:5:5 molar ratio))
						
						Product description
							Cationic Liposomes (Lyophosome-PEGylated)(DSPC:Chol:DSTAP:PEG2000-DSPE (60:30:5:5 molar ratio)),Cationic liposomes interact with negatively charged glycoproteins on the cell surface, thereby increasing the affinity and residence time with the target cells,resulting in increased drug delivery.Conventional liposomal formulations reduced the toxicity of compounds in vivo, through modifying pharmacokinetics and biodistribution to enhance drug delivery to diseased tissue in comparison to free drug.
| Appearance | N/A | 
|---|---|
| Buffer | Deionized water | 
| Liposome size | 100 nm (after hydration) | 
| Lyoprotectant | Trehalose | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃temperature for up to 3 weeks | 
| Stability | 1 year | 
Document
							Related Product
							
						
Items-$0.00

Email:
Tel.:
MSDS---Cationic Liposomes (Lyophosome-PEGylated)(DSPC:Chol:DSTAP:PEG2000-DSPE (60:30:5:5 molar ratio)) 
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

